{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Nexalin Technology, Inc."},"Symbol":{"label":"Symbol","value":"NXL"},"Address":{"label":"Address","value":"1776 YORKTOWN,SUITE 550, HOUSTON, Texas, 77056, United States"},"Phone":{"label":"Phone","value":"+1 713 660-1100"},"Industry":{"label":"Industry","value":"Biotechnology: Electromedical & Electrotherapeutic Apparatus"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Nexalin Technology Inc design and develop innovative neurostimulation products to uniquely and effectively help combat the ongoing global mental health epidemic."},"CompanyUrl":{"label":"Company Url","value":"https://www.nexalin.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"David Owens","title":"Director & Chief Medical Officer"},{"name":"John Patrick Claude","title":"Director-Engineering & Development"},{"name":"Mark White","title":"President, Chief Executive Officer, CFO & Director"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}